The "materiality" threshold for disclosing information applies only to a company's own stock—not to the stock of competitors and prospective competitors. So, Big Pharma are not violating SEC regs in the instances you cite. The behavior is somewhat shady, but it's not unlawful.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.